Company news

SanBio Co., Ltd. news in 2024

SanBio Co., Ltd.'s news releases, calls and decks from 2024, newest first.

View company

SanBio Obtains Marketing Approval for AKUUGO Suspension for Intracranial Implantation as a Therapeutic Agent for Improving Chronic Motor Paralysis from Traumatic Brain Injury

August 1, 2024

SanBio Obtains Marketing Approval for “AKUUGO® Suspension for Intracranial Implantation” (INN: Vandefitemcel) as a Therapeutic Agent for Improving Chronic Motor Paralysis From Traumatic Brain Injury (TBI)

July 31, 2024